ArticleNeurosurgical review2026
Anxiety and depression symptoms after angiographically negative spontaneous subarachnoid hemorrhage.
Article in Neurosurgical review, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectiveTo investigate the risk factors of anxiety and/or depression after angiographically negative spontaneous subarachnoid hemorrhage (anSAH).
methodsWe performed a retrospective review of a prospectively database for anSAH patients between January 2014 and June 2019. AnSAH was defined as SAH present in CT scans with no underlying vascular abnormality on initial digital subtraction angiography (DSA). Baseline demographics, angiographic features and hospitalization course were carefully reviewed. Depression or anxiety symptoms were assessed with the Hamilton Scales for anxiety and depression (HAMA and HAMD). Anxiety symptom and depression symptom were defined as a total score of HAMA–14 > 7 points and HAMD–24 ≥ 8 points, respectively.
resultsAmong 310 enrolled patients, anxiety and/or depression symptoms occurred in 34 (11.0%) patients. Multivariate logistic analysis showed that age < 55 years, modified Fisher Scale (mFS) 3–4 and length of hospital stays (LOS) > 10 days were independent risk factors of anxiety and/or depression in patients with anSAH. Additionally, the area under characteristic for multivariate factors (age, mFS and LOS) was 0.703. The incidence rate for anxiety and/or depression symptoms in the low-risk group (without any of risk factors) and high-risk group (with three risk factors) was 2.78% and 33.30%, respectively.
conclusionsIn patients with anSAH, age < 55 years, mFS 3–4 and LOS > 10 days were associated with a high risk of anxiety and/or depression symptoms, and these factors demonstrated acceptable predictive efficacy for psychological distresses. Furthermore, the incidence of anxiety and/or depression in the high–risk group was high, warranting the need for early psychological support in this group.
Indexed as
Identifiers
41915278What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.